Amniotic Products Market by Type (Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions), Application (Wound Care, Ophthalmology, Orthopedics), End User (Hospitals, ASCs) - Global Forecast to 2026
Instant Answers with GPT - Ask Now!
Ask real questions. Get complete answers !
Generating Response ...[205 Pages Report] The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management, rising venture capital investments and government funding, increasing number of traumatic wounds, growing number of amniotic membrane transplantations, and the increasing number of ophthalmology, cosmetic, and orthopedic surgeries. Emerging economies, implementation of the 21st-century cures act, and increasing demand for stem cell research and regenerative medicine are expected to offer strong growth opportunities for players in the market. In contrast, the complications and limitation associated with the use of amniotv membrane may challenge market growth to a certain extent. The amniotic products market is segmented based on type, application, end user, and region.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 impact on the amniotic products market
The COVID-19 outbreak negatively impacted the amniotic products market in 2020 due to nationwide lockdowns, denied wound care services, and canceled or postponed elective surgeries. Elective surgeries were being denied (canceled/postponed) to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) towards COVID-19 patient care. In addition, various countries had enforced lockdowns and curfews to curb the rising number of COVID-19 cases. Due to these lockdowns, patients were not able to visit hospitals, OPDs, or clinics. This temporary denial of non-emergent healthcare services is expected to limit the growth of the amniotic products market. However, the demand for amniotic products is expected to rise in the coming years.
Global Amniotic products Market Dynamics
DRIVER: Rising incidence of burn injuries
The high incidence of burn wounds has resulted in a significant increase in the demand for wound care biologics, including amniotic membranes. According to the WHO, a majority of burn cases occur in low- and middle-income countries, and almost two-thirds occur in the WHO African and Southeast Asian regions. For instance, in India, 1 million people suffer from moderate and severe burns every year (Source: WHO). The incidence of burns is also high in other Southeast Asian countries such as Bangladesh and Nepal. An estimated 173,000 children suffer from moderate or severe burns in Bangladesh every year. In Nepal, burns are the second-most common injury, accounting for 5% of all disabilities.
OPPORTUNITY: Implementation of the 21st Century Cures Act (US)
The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation. The Act covers various provisions that may impact the development and approval of several products in the coming years. Under this Act, a new “Regenerative Medicine Advanced Therapy” designation has been established, along with a fast-track approval pathway for new regenerative medicine products and therapies. The implementation of this Act can potentially result in the approval of new regenerative medicine products and therapies in the US, as well as stimulate R&D activities in the field of regenerative medicine.
CHALLENGE: Complications and limitations associated with the use of amniotic membranes
Amniotic membranes are not to be used indiscriminately since there could be an occasional risk of complications. The patient or the recipient of an amniotic membrane could transmit bacterial, viral, or fungal infections if the donors are not adequately screened for communicable diseases. Other risks to the patient/recipient may also occur if the membrane is not processed under sterile conditions, or if the membrane is inappropriately stored. Incidence rates of 1.6% to 8.0% have been reported post amniotic membrane transplantation, with gram-positive isolates being reported most frequently. Also, premature degradation of an amniotic membrane and cheese wiring may further lead to frequent and repetitive transplantations, which in itself is a risk.
Amniotic membrane segment dominated the Amniotic products market in 2020.
Based on type, the amniotic products market is segmented into amniotic membranes and amniotic suspensions. Amniotic membrane account for the largest share of the amniotic products market. The large share of this segment can be attributed to its increased use in a number of procedures. Moreover, amniotic membranes are more effective than amniotic suspensions.
The wound care segment to witness the highest CAGR during the forecast period.
Based on application, the amniotic products market is segmented into wound care, ophthalmology, orthopedics, and other applications. The wound care applications segment commanded the largest share of the amniotic products market. . The large share of this segment can be attributed to the growing incidence of ulcers, traumatic and surgical wounds, and burns and the need for advanced technologies for treatment.
North America was the largest regional market for amniotic products market in 2020.
The global amniotic products market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, and the Rest of Asia Pacific), Latin America and Middle East & Africa. In 2020, North America dominated the global amniotic products market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of target diseases, increasing geriatric population, rising awareness about advanced treatment options, and the strong presence of key market players in the region.
Key Market Players
The prominent players operating in this market include MiMedx (US), Smith & Nephew (UK), Organogenesis Inc. (US), and Integra LifeScienes (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2019–2026 |
|
Base year considered |
2019 |
|
Forecast period |
2021–2026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Type, Application, End User and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Companies covered |
MiMedx (US), Smith & Nephew (UK), Organogenesis Inc. (US), Integra LifeSciences (US), Stryker (US), Applied Biologics (US), Celularity, Inc. (US), Katena Products, Inc. (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics Holdings, LLC (US), Surgenex (US), TissueTech, Inc. (US), Ventris Medical, LLC (US), StimLabs LLC (US), VIVEX Biologics, Inc. (US), LifeCell International Pvt. Ltd. (India), NuVision Biotherapies Ltd. (UK), Genesis Biologics (US), Surgilogix (US), Tides Medical (US), Orthofix Medical Inc. (US), AlloSource (US), Merakris Therapeutics (US), and MTF Biologics (US). |
This report categorizes the amniotic products market into the following segments and subsegments:
By Type
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
By Application
- Wound Care
- Orthopedics
- Ophthalmology
- Other Applications
By End User
- Hospitals & ASCs
- Other End Users
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In 2021, Integra LifeSciences (US) acquired ACell, Inc, (US) to broaden the advanced wound care portfolio of the company.
- In 2021, Organogenesis Inc. (US) launched ReNu an amniotic suspension, the company also received approval from the US FDA by granting the Regenerative Medicine Advanced Therapy designation for use in knee osteoarthritis.
- In 2021, MiMedx (US) received approval from the Japanese Ministry of Health, Labour and Welfare for the commercialization of EPIFIX in Japan.
- In 2019, Smith & Nephew (UK) acquired Orisis Therapeutics (US) for USD 660 million to develop and market regenerative medicine products for wound care, orthopedics, and sports medicine.
Frequently Asked Questions (FAQ):
What is the impact of COVID-19 on the amniotic products market?
The COVID-19 pandemic has a negative impact on amniotic products. The reduced use of amniotic products due to the declining volume of elective and non-essential procedures, the lower diagnosis, reduced capital spending by customers, and a decrease in research activity due to laboratory closures and reduced clinical testing have all affected the market.
Who are the key players in the amniotic products market?
The prominent players operating in this market include MiMedx (US), Smith & Nephew (UK), Organogenesis Inc. (US), and Integra LifeSciences (US).
Which product dominates the amniotic products market?
Amniotic membrane account for the largest share of the amniotic products market. The large share of this segment can be attributed to its increased use in a number of procedures. Moreover, amniotic membranes are more effective than amniotic suspensions.
What factors are driving the amniotic products market?
Market growth is largely driven by factors such as to the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management, rising venture capital investments and government funding, increasing number of traumatic wounds, growing number of amniotic membrane transplantations, and the increasing number of ophthalmology, cosmetic, and orthopedic surgeries.
What is the market for global amniotic products?
The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
FIGURE 1 AMNIOTIC PRODUCTS MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1 GROWTH FORECAST
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
2.8 GROWTH RATE ASSUMPTIONS
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 10 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 AMNIOTIC PRODUCTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 13 AMNIOTIC PRODUCTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 48)
4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW
FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
4.2 AMNIOTIC PRODUCTS MARKET, BY TYPE (2021–2026)
FIGURE 15 AMNIOTIC MEMBRANES SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE AND COUNTRY (2020)
FIGURE 16 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN AMNIOTIC PRODUCTS MARKET IN 2020
4.4 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 US AND UK TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 51)
5.1 INTRODUCTION
FIGURE 18 AMNIOTIC PRODUCTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the target patient population
TABLE 1 GLOBAL PREVALENCE OF DIABETES
5.2.1.2 Rising incidence of burn injuries
5.2.1.3 Awareness programs for wound care treatment and management
TABLE 2 WOUND CARE AWARENESS INITIATIVES
5.2.1.4 Rising venture capital investments and government funding
TABLE 3 FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH UNDER THE 21ST CENTURY CURES ACT
FIGURE 19 ARTICLES RELATED TO AMNIOTIC PRODUCTS PUBLISHED FROM 2010 TO 2020
5.2.1.5 Increasing number of traumatic wounds
5.2.1.6 Growing number of amniotic membrane transplantations
TABLE 4 NO. OF AMNIOTIC MEMBRANE TRANSPLANTATIONS PERFORMED IN UNIVERSITY EYE HOSPITAL TÜBINGEN, GERMANY
5.2.1.7 Increasing number of ophthalmology, cosmetic, and orthopedic surgeries
5.2.2 OPPORTUNITIES
5.2.2.1 Emerging economies
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC
5.2.2.2 Implementation of the 21st Century Cures Act (US)
5.2.2.3 Increasing demand for stem cell research and regenerative medicine
FIGURE 20 STEM CELL RESEARCH FUNDING IN THE LAST 10 YEARS
TABLE 6 NIH FUNDING FOR CELL-BASED RESEARCH, 2016–2021 (USD MILLION)
5.2.3 CHALLENGES
5.2.3.1 Complications and limitations associated with the use of amniotic membranes
5.3 RANGES/SCENARIOS
5.3.1 AMNIOTIC PRODUCTS MARKET
FIGURE 21 PESSIMISTIC SCENARIO
FIGURE 22 OPTIMISTIC SCENARIO
FIGURE 23 REALISTIC SCENARIO
5.4 COVID-19 IMPACT ON THE AMNIOTIC PRODUCTS MARKET
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.5.1 REVENUE SHIFT & REVENUE POCKETS FOR AMNIOTIC PRODUCT MANUFACTURERS
5.5.2 REVENUE SHIFT FOR THE AMNIOTIC PRODUCTS MARKET
5.6 PRICING ANALYSIS
TABLE 7 PRICES OF AMNIOTIC PRODUCTS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 24 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.8 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE DEVELOPMENT PHASE
5.9 ECOSYSTEM ANALYSIS
5.9.1 ROLE IN THE ECOSYSTEM
TABLE 8 ROLE OF KEY PLAYERS IN THE ECOSYSTEM
FIGURE 26 KEY PLAYERS IN THE AMNIOTIC PRODUCTS ECOSYSTEM
5.10 TECHNOLOGY ANALYSIS
5.11 PATENT ANALYSIS
5.12 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 10 EXPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY, 2016-2020 (USD MILLION)
5.13 REGULATORY LANDSCAPE
5.13.1 NORTH AMERICA
5.13.2 EUROPE
5.13.3 EMERGING COUNTRIES
5.14 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 PORTER’S FIVE FORCES ANALYSIS
5.14.1 INTENSITY OF COMPETITIVE RIVALRY
5.14.2 BARGAINING POWER OF SUPPLIERS
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 THREAT OF SUBSTITUTES
5.14.5 THREAT OF NEW ENTRANTS
6 AMNIOTIC PRODUCTS MARKET, BY TYPE (Page No. - 73)
6.1 INTRODUCTION
6.2 PRIMARY NOTES
TABLE 12 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 13 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
6.3 AMNIOTIC MEMBRANES
TABLE 14 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 15 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 16 AMNIOTIC MEMBRANES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 17 AMNIOTIC MEMBRANES MARKET, BY REGION, 2020–2026 (USD MILLION)
6.3.1 CRYOPRESERVED AMNIOTIC MEMBRANES
6.3.1.1 Cryopreserved amniotic membranes will dominate the amniotic membranes market during the forecast period
TABLE 18 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 19 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2020–2026 (USD MILLION)
6.3.2 DEHYDRATED AMNIOTIC MEMBRANES
6.3.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth
TABLE 20 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 21 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2020–2026 (USD MILLION)
6.4 AMNIOTIC SUSPENSIONS
6.4.1 ANTI-INFLAMMATORY AND ANTIMICROBIAL PROPERTIES OF AMNIOTIC SUSPENSIONS TO DRIVE MARKET GROWTH
TABLE 22 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 23 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2020–2026 (USD MILLION)
7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION (Page No. - 81)
7.1 INTRODUCTION
7.2 PRIMARY NOTES
TABLE 24 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 25 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
7.3 WOUND CARE
7.3.1 WOUND CARE IS THE LARGEST APPLICATION SEGMENT OF THE AMNIOTIC PRODUCTS MARKET
TABLE 26 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION, 2017–2019 (USD MILLION)
TABLE 27 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION, 2020–2026 (USD MILLION)
7.4 ORTHOPEDICS
7.4.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 28 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2017–2019 (USD MILLION)
TABLE 29 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2020–2026 (USD MILLION)
7.5 OPHTHALMOLOGY
7.5.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY
TABLE 30 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2017–2019 (USD MILLION)
TABLE 31 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2020–2026 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 32 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2019 (USD MILLION)
TABLE 33 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
8 AMNIOTIC PRODUCTS MARKET, BY END USER (Page No. - 89)
8.1 INTRODUCTION
TABLE 34 AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 35 AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
8.2 HOSPITALS & AMBULATORY SURGERY CENTERS
8.2.1 HOSPITALS & ASCS FORM THE LARGEST END-USER SEGMENT OF THE AMNIOTIC PRODUCTS MARKET
TABLE 36 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
TABLE 37 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION, 2017–2019 (USD MILLION)
TABLE 38 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION, 2020–2026 (USD MILLION)
8.3 OTHER END USERS
TABLE 39 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2017–2019 (USD MILLION)
TABLE 40 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION)
9 AMNIOTIC PRODUCTS MARKET, BY REGION (Page No. - 95)
9.1 INTRODUCTION
TABLE 41 AMNIOTIC PRODUCTS MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 42 AMNIOTIC PRODUCTS MARKET, BY REGION, 2020–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET SNAPSHOT
TABLE 43 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 44 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 45 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 46 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 47 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 48 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 50 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 52 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American amniotic products market
TABLE 53 US: KEY MACROINDICATORS
TABLE 54 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 55 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 56 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 57 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 58 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 59 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 60 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 61 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth
TABLE 62 CANADA: KEY MACROINDICATORS
TABLE 63 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 64 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 65 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 66 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 67 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 68 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 69 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 70 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3 EUROPE
TABLE 71 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 72 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 73 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 74 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 75 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 76 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 77 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 78 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 79 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 80 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3.1 UK
9.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2020
TABLE 81 UK: KEY MACROINDICATORS
TABLE 82 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 83 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 84 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 85 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 86 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 87 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 88 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 89 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Increasing incidence of diabetes to drive market growth in Germany
TABLE 90 GERMANY: KEY MACROINDICATORS
TABLE 91 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 92 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 93 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 94 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 95 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 96 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 97 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 98 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising government support to drive the demand for amniotic products in France
TABLE 99 FRANCE: KEY MACROINDICATORS
TABLE 100 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 101 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 102 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 103 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 104 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 105 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 106 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 107 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.3.4 REST OF EUROPE
TABLE 108 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 109 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 110 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 111 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 112 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 113 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 114 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 115 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 116 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET SNAPSHOT
TABLE 117 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 118 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 120 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 121 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 122 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 124 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 125 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 126 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to dominate the Asia Pacific amniotic products market during the forecast period
TABLE 127 CHINA: KEY MACROINDICATORS
TABLE 128 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 129 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 130 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 131 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 132 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 133 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 134 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 135 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Growing geriatric population to drive market growth in Japan
TABLE 136 JAPAN: KEY MACROINDICATORS
TABLE 137 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 138 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 139 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 140 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 141 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 142 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 143 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 144 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 145 ROAPAC: DIABETES PREVALENCE (% OF POPULATION AGED 20–79), BY COUNTRY, 2019
TABLE 146 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 147 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 148 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 149 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 150 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 151 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 152 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 153 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
TABLE 154 LATIN AMERICA: DIABETES PREVALENCE (% OF POPULATION AGED 20–79), BY COUNTRY, 2019
TABLE 155 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 156 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 157 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 158 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 159 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 160 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 161 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 162 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 SIGNIFICANT GROWTH IN HEALTHCARE INFRASTRUCTURE AND GOVERNMENT INITIATIVES TO FAVOR MARKET GROWTH
TABLE 163 MIDDLE EAST & AFRICA: DIABETES PREVALENCE (% OF POPULATION AGED 20–79), BY COUNTRY, 2019
TABLE 164 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 147)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY AMNIOTIC PRODUCT MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE AMNIOTIC PRODUCTS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 30 AMNIOTIC PRODUCTS MARKET SHARE ANALYSIS, 2020
TABLE 173 AMNIOTIC PRODUCTS MARKET: DEGREE OF COMPETITION (2020)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 31 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT (2020)
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
TABLE 174 DEALS
10.7.2 PRODUCT LAUNCHES & APPROVALS
TABLE 175 PRODUCT LAUNCHES & APPROVALS
10.7.3 OTHER DEVELOPMENTS
TABLE 176 OTHER DEVELOPMENTS
10.8 COMPANY FOOTPRINT ANALYSIS
TABLE 177 COMPANY FOOTPRINT ANALYSIS
TABLE 178 COMPANY PRODUCT FOOTPRINT
TABLE 179 COMPANY REGIONAL FOOTPRINT
11 COMPANY PROFILES (Page No. - 161)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 MIMEDX
TABLE 180 MIMEDX: BUSINESS OVERVIEW
FIGURE 33 MIMEDX: COMPANY SNAPSHOT (2020)
11.1.2 SMITH & NEPHEW PLC
TABLE 181 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 34 SMITH & NEPHEW: COMPANY SNAPSHOT (2020)
11.1.3 ORGANOGENESIS INC.
TABLE 182 ORGANOGENESIS INC.: BUSINESS OVERVIEW
FIGURE 35 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)
11.1.4 INTEGRA LIFESCIENCES
TABLE 183 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 36 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
11.1.5 STRYKER
TABLE 184 STRYKER: BUSINESS OVERVIEW
FIGURE 37 STRYKER: COMPANY SNAPSHOT (2020)
11.1.6 APPLIED BIOLOGICS
TABLE 185 APPLIED BIOLOGICS: BUSINESS OVERVIEW
11.1.7 CELULARITY INC.
TABLE 186 CELULARITY INC.: BUSINESS OVERVIEW
11.1.8 KATENA PRODUCTS, INC.
TABLE 187 KATENA PRODUCTS, INC.: BUSINESS OVERVIEW
11.1.9 LUCINA BIOSCIENCES
TABLE 188 LUCINA BIOSCIENCES: BUSINESS OVERVIEW
11.1.10 NEXT BIOSCIENCES
TABLE 189 NEXT BIOSCIENCES: BUSINESS OVERVIEW
11.1.11 SKYE BIOLOGICS HOLDINGS, LLC
TABLE 190 SKYE BIOLOGICS HOLDINGS, LLC: BUSINESS OVERVIEW
11.1.12 SURGENEX
TABLE 191 SURGENEX: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 TISSUETECH, INC.
11.2.2 VENTRIS MEDICAL, LLC
11.2.3 STIMLABS LLC
11.2.4 VIVEX BIOLOGICS
11.2.5 LIFECELL INTERNATIONAL PVT. LTD.
11.2.6 NUVISION BIOTHERAPIES LTD
11.2.7 GENESIS BIOLOGICS
11.2.8 SURGILOGIX
11.2.9 TIDES MEDICAL
11.2.10 ORTHOFIX MEDICAL INC.
11.2.11 ALLOSOURCE
11.2.12 MERAKRIS THERAPEUTICS
11.2.13 MTF BIOLOGICS
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 198)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the amniotic products market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the amniotic products market. The secondary sources used for this study include National Center for Biotechnology Information (NCBI), Organisation for Economic Co-operation and Development (OECD), Association for the Advancement of Wound Care (AAWC), Journal of Wound Care (JWC), American Physical Therapy Association (APTA), National Alliance of Wound Care and Ostomy (NAWCO), European Wound Management Association (EWMA), National Institute for Health and Care Excellence (NICE), National Institutes of Health (NIH), International Life Sciences Institute (ILSI), US Food and Drug Administration (US FDA), American Medical Association (AMA), Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Eurostat, SEC Filings, Annual Reports, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the amniotic products market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the amniotic products business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global amniotic products market based on the type, application and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall amniotic products market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the amniotic products market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Company Information
- An additional five company profiles
Growth opportunities and latent adjacency in Amniotic Products Market